Guided Therapeutics Inc (QB) (GTHP) Quote

What’s a good price to buy Guided ? That DNDN SPNG bring back memories. Buxton hot for your Twins. Citius mid pulled my post there a few hours ago . He very CitiusOK !! When are you gonna sell Guided Therapeutics ??

The L2 Asks under 55 cents disappeared for a while.

They're back. I got excited, sorry.

GTHP#$$: Hey Bulba and JuneBugs once and when this Loin Puppy gets FDA approval or any other national approval . It will become the target of a Buy Out. It won't be a $.25 pps but a $10 pps . Now you know why it's so hard to buy shares. I believe it to be the next Cologuard .

Actually the opposite is true...The home HPV test would increase the number of LuViva tests in the US because a positive HPV test would need to be resolved by LuViva. Important to note that an HPV test only detects the presence of the virus and not whether cancer is starting. Only about 1 out of 100 HPV infections result in cervical cancer, so you need LuViva to determine the likelihood of this happening.

The question is: Will a new at-home test for cervical cancer harm LuViva's prospects?

I have held a few shares and was day trading until i got a friggin job. Now, i lost a crap load of opportunity. 10 years later, i have a buy order in for 51k shares tomorrow. I think we are almost there. 

I didn't see that while I was typing the other response, LOL.

I like this: "HDMT will order directly from Guided Therapeutics." I'd be disappointed if HDMT was ordering directly from SMI and Guided had to trust SMI to handle the money.

I wish I knew what this means in regards to the NMPA. Maybe there will be an 8-K with details? There must be a contingency where HDMT won't pay the entire $700k until the NMPA approves the device.

Money from HDMT is separate from SMI payments. The good news -- no, GREAT news -- is this kind of revenue will allow Guided to repay the 1800 Diagonal Lending debt without having it become convertible. I will be happy to see 1800 Diagonal Lending go away.

I assume you noticed in the 10-Q that they didn't ship to Indonesia in Q1 -- we know that because they didn't book the Indonesia money as revenue yet. It's still Deferred Revenue. That's why I say it reminds me of the old Turkey PR's.

That said, I've been "accumulating" for well over a year now. It's hard to get sellers to part with GTHP for less than the ASK but I keep trying, like good ol' AlmondJoy who was buying the entire time he was bashing.

I own a lot of GTHP. I don't expect miracles but I do expect profits.

Best of luck to all who have done their DD here!

Just saw this out now.

Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor

While i agree with you that the NMPA approval and completion of the USFDA study are the 2 massive catalyst events, i don't necessarily mind that the article focussed on events that have transpired and have been paid for. Hopefully the writer starts to give credit if the new "financial partner" starts delivering...and ON TIME!!!

With all that said, if you spend some time reading the Q's (which i know you do), it seems pretty obvious that this is a screaming opportunity at these levels!!!

That's a good article, but the author completely omitted/ignored SMI and China and the NMPA.

I still don't think SMI is going to come up with the $$$ millions they promised, but the NMPA approval is the next potential catalyst. IF the NMPA approves the device, SMI should be able to come up with enough money to take care of operating costs until FDA clearance, IMO.

Without NMPS approval, we're going to see nickel-and-dime financing, potentially with shady actors like 1800 Diagonal Lending.

The author lists Indonesia instead of China as the first catalyst for 2025. I remember the hype about Turkey, years ago, that turned out to be.... a turkey.

But it's good to see a little press on GTHP! Thanks for posting that!

Very pleased to see the new "investment partners" for SMI. Also very encouraged with them being very close to completing the USFDA study.
I also found an interesting report for those interested in the UPSIDE potential of the story!!

https://gekkovswolf.com/disrupting-cervical-cancer-detection-at-the-edge-of-the-frontier-a-deep-value-bet-on-life-saving-biophotonics/

The good news about the $100,000 payment: it's straight revenue, not deferred revenue.

The bad news: it's only $100,000. SMI promised a lot more than that. For example, SMI promised to pay $4.4 million 2024 which they did not pay.

The GREAT news: SMI has "investment partners." We all knew that SMI didn't have a pot in which to.... make soup. but now they have "investment partners." It means Guided might actually get some of the money promised by SMI, and SMI has promised a LOT of money. Short term, SMI could solve Guided's 2025 cash flow problem while they wait for US FDA approval. From the 10-Q:Under the Extension Agreement, GTI and SMI agreed to new payment terms, including immediate payments of $100,000 for RFID chips and $30,000 for device parts by May 10, 2025, and a revised installment schedule for the remaining $300,000 balance. SMI also agreed to pay $1,351,250 for instrumentation packages by September 30, 2025. Additional milestones were established, including requirements to (i) demonstrate commercialization of LuViva in China by September 30, 2025, (ii) pass manufacturing inspections, and (iii) demonstrate the ability to manufacture cervical guides to GTI’s specifications by July 30, 2025.

GTHP Ownership:

Hedge Funds________4,248,474______5.38%
Private companies____6,095,386______7.72%
VC/PE Firms________9,135,152______11.60%
General public______26,556,278______33.70%
Individual Insiders___32,874,889______41.70%

O/S Total: 78,910,179


https://simplywall.st/stocks/us/healthcare/otc-gthp/guided-therapeutics/ownership

Regarding 1800 Diagonal Lending.....

GTHP also borrowed money from them last year, but that wasn't convertible and I believe those have been paid (or will be by the maturity date of May 30, 2025).

1800 Diagonal Lending has a history of immediately dumping shares they acquired through note conversion. The SEC just instigated proceedings against Mark Cramer, sole owner of 1800 Diagonal Lending and two other LLC's he uses to lend money, for dumping converted shares so fast that he's acting like a securities dealer. The SEC calls him a "two-time recidivist violator."
https://www.sec.gov/files/litigation/complaints/2024/comp25995.pdf

GTHP's two new loans mature on January 30th, 2026 and February 28, 2026. It's important not to default on these loans because the loans aren't convertible unless GTHP defaults.

By 2026, there's a decent chance the PMA could be approved. I wish I could say there's a decent chance SMI will pay $$$ millions by 2026 but I can't say that with a straight face. I can't even say the NMPA will approve the Luviva scan this year. SMI just keeps lying about paying their bills so who knows how much of their NMPA story we can believe. I believe that doctors in China completed the Chinese clinical trial and the results were great, but those doctors didn't submit an application to the NMPA -- SMI did.

The most important part of the 10-Q: US Clinical trials. As of May 1, 2025, approximately 360 patients have been enrolled and tested, which represents approximately ninety percent of the 400 anticipated patients needed to complete the study. When they field their 10-K they said "To date, approximately 320 patients have been enrolled and tested." If "To Date" meant March 31st, they completed 40 patients between March 31st and May 1st, which is faster than expected, since they have been moving at a rate of about 50 per quarter.

I wish they had said "As of [mm/dd/yyyy]" instead of "To date" in the 10-K, but I'm expecting the US clinical trials to finish by the end of Q2 or shortly thereafter. That will be a welcome PR!

I don't think it will take GTHP much time to file the amended PMA after the clinical trials finish because GTHP has had nothing else to do but prepare, and I don't think the FDA will take much time to approve the PMA because it's not a new PMA -- it's an amendment to a PMA that was first submitted in 2010. Of course, in the world of developmental biotech, nothing happens as fast as expected.

10-Q out, No revenues booked in Q1.

Deferred Revenue reduced by $179,000 because the company took $180,000 of SMI money and applied it to reimbursement of expenses the Company incurred in prior periods.

They borrowed money from an entity called "Diagonal Lending LLC" and it's convertible if GTHP defaults. It's important to note that the notes aren't convertible UNLESS GTHP defaults. Have to keep an eye on this SEC case against Diagonal Lending et al:

https://www.sec.gov/files/litigation/complaints/2024/comp25995.pdf

No real news on SMI or the NMPA. To nobody's surprise, SMI failed to pay again, and they signed another Extension Agreement. We're all waiting to see what the NMPA does of course.

Really wondering what happened to JoJo and his other aliases. His latest alias lasted for just one post.

I'm bored so I read the 10-K a little more carefully, and this surprised me -- might be a typo? Our Chinese partner, SMI, filed the application with NMPA for approval of LuViva as a Class 3 medical device in China on October 16, 2024. I thought SMI filed for a Class 2 device. Class 2 and 3 in China are not the same as Class 2 and Class 3 in the USA.

oh well, NMPA decision very likely in Q2 so let's gird our loins. Meanwhile, here's some Safe Harbor hype from the 10-K: In Europe, our distribution partners, Newmars Medical Technologies (“Newmars”), is actively pursuing potential customers in Poland, Hungary and Romania, where we have obtained the required approvals to sell our products though Newmars. In addition, an application for approval has been filed in Russia, although current geopolitics presents uncertainty as to the ability to sell and market new medical technology in that country.

In Turkey, we have been in contact with three different medical groups representing over 60 individual hospitals and clinics. We have entered contract discussions for supplying LuViva to the Turkish Ministry of Health and also with a medical device distributor located in Ankara.

In Indonesia, our contracted distributors are in discussions with the local government hospital system of Sulawesi, one of the nation’s most populous islands. During the fourth quarter of 2024, we received an order and full payment for four devices from Indonesia. We expect additional orders for 22 – 26 devices in 2025.

Thanks

Appreciate the through response.

Thanks

Just another Form 4. Insider acquiring more shares -- direct purchase to fund the company and get more warrants, and a conversion of debt into stock.

So --

* good, in that insiders continue to fund the company without a return to toxic lenders.

* indifferent, in that it's only $15k new money now.

* indifferent, in that an 8-K about SMI paying money would have been better. (Tongue in cheek)

on a different note: OTC tickers like GTHP aren't directly falling because of the tariff crash, but they are indirectly getting hurt because shareholders are selling bits and pieces of all their holdings, presumably to pay for margin calls in their fund/ETF accounts. Examples: in GTHP, somebody put a large block up for sale at .08, and in RDGL, somebody put up a large block at 10-11 cents. It's not because something is wrong with GTHP or RDGL -- it's because something is REALLY wrong elsewhere.

Personally, I don't use margin and I'm not old enough to have RMD's, so this tariff crash isn't affecting me. It's a buying opportunity, if anything.

I'm half expecting to hear from Jojo again. He was a big buyer last year at .09. I guess he doesn't want to bash when the PPS is .09 or lower.


GTHP

Filing out today.

Good, bad, or indifferent???

10-K out. As of 12/31/2024 they had $849,000 in deferred revenue, some of which must be SMI and some of which must be that order they sold in Q4 but didn't book by EOY (because there's not much revenue booked in 2024).

SMI is up to their old tricks, which should surprise NOBODY. SMI has paid $855,144 so far total, but they missed their payments again in 2024, forcing yet ANOTHER update to the AMI Agreement (see pages F-29 and F-30): To meet demand for the remainder of 2024 and for the first half of 2025, SMI agreed to purchase a minimum of 500,000 RFID chips, at prices ranging between $1.00 and $1.40 per chip. To meet demand for the second half of 2025, SMI agreed to purchase an additional 100 IPs and 1,000,000 RFID chips, at prices ranging between $1.00 and $1.40 per chip. SMI agreed to pay a minimum of $400,000 to the Company prior to December 31, 2024, to cover additional components, devices and costs incurred by the Company. On January 3, 2025, after confirming with SMI that no payment was forthcoming, the Company notified SMI in writing that the failure to make this payment constituted a breach of the October 21, 2024 Agreement. A second non-monetary breach also was identified in the Company’s correspondence to SMI. SMI informed the Company that it intended to cure the monetary breach and the Company agreed to negotiate a partial settlement by April 1, 2025.

If by April 30, 2025, SMI fails to achieve commercialization of LuViva in China, SMI shall no longer have any rights to manufacture, distribute or sell LuViva. So maybe we'll see a PR tomorrow about a payment from SMI? hahahaha just kidding. Of interest here, though, is that Guided seems to be preparing to kick SMI to the curb, finally, because of that line about "commercialization by April 30."

NMPA approval by April 30? We'll see. Commercialization by April 30? Not a chance. However, this is new: On January 6, 2025, SMI informed us that NMPA found the application complete and was commencing their review. The most important catalyst: US Clinical trials. My prediction ten days ago was "I expect them to say 'over 300 enrolled' in the annual report." Here's the synopsis of the most recent PMA Amendment: We held a follow up teleconference with FDA on January 28, 2020 and filed a pre-submission document to the Agency on February 17, 2020 that summarized the clinical protocol to be submitted for FDA review. In the second quarter of 2021, we reached basic agreement with the FDA on a study protocol that would require approximately 400 women to be tested. During 2022, FDA asked for a few additional clarifications which we resolved, allowing for the study to begin in 2023. To date, approximately 320 patients have been enrolled and tested. In summary: No surprises, good or bad, other than MAYBE the company is ready to show SMI the door.

We're still under the radar. Let's watch for NMPA news in April.

My US Trials timeline prediction looks correct.

They updated the clinicaltrials.gov site today. Estimated completion of trial: July 31, 2025. Since the protocol states that the outcome measures happen "up to 60 days after completion of enrollment," that means they expect to complete enrollment in May 2025. I expect them to say "over 300 enrolled" in the annual report.

The company probably won't know about the Chinese NMPA decision when they file the 10-K.... too soon, IMO, unless there were issues.


.

There's no reverse split on the horizon. The O/S is only 66 million and they won't be uplisting to NASDAQ any time soon and the death spiral financing is long gone, so there's no reason whatsoever to do a R/S.

Here's what's on the horizon:

* Finish US clinical trials.
* Submit a PMA addendum to the FDA.
* NMPA (Chinese FDA) decision.

10-K due at the end of the month. They sold a little product in Q4 but probably not enough to matter (we'll see how much). We'll also see if SMI paid any money -- unlikely, IMO, but if the NMPA approves the device, Guided can find a way to kick SMI to the curb and capitalize -- SMI has served their purpose. Even if the NMPA doesn't approve, that Chinese clinical trial makes the PMA addendum as close to a slam dunk as you can get with the FDA.

Officers (insiders) own 25% of the O/S. Auctus and GPB Holdings own another 25%. That leaves only 33 million in the hands of investors like us. Nothing is guaranteed, but if/when this thing runs, that low float could make it run pretty hard. I like the odds.



GTHP

....from 50 cents to a dime over the past few years. It looks like, yet, another reverse split is on the horizon .......even with so little stock remaining.

Timeline musings.......

I think they will reach the US 400-patient goal in Q2.

The last count was 255 patients at the end of Q3. They were moving along at about 50 patients a quarter. They did about 80 between Q1 and Q2 last year but it really looks like about 50 per quarter. I expect them to say "over 300" in the annual report.

Chinese NMPA approval timeline: about six months if no problems. They submitted in Oct 2024.

The annual financial statement in four weeks will be interesting because we'll see if they got any money from SMI in Q4. I still don't think SMI has any money to GIVE, but there would be no point of completing the clinical trials in China and submitting to the NMPA if they didn't have some sort of a plan. Wouldn't an SMI payment be a nice surprise. Won't matter much in terms of PPS, IMO, because this ticker is still under the radar and will stay there until the FDA play later in 2025, but without SMI money they'll probably have to dilute again before the EOY.




't

Welcome to iHub!

myjo and myjog are the same person. He or she used those two aliases to create fake conversations about GTHP, against iHub rules. That kind of attempted manipulation is a criminal act.

Also, that person instigated the cyber bullying and cyber harassing between us. Yes, I took up the gauntlet, and I will again if someone tries bullying and harassing me.

Like, for example, if myjo/myjog comes back with a new alias and picks up where he or she left off.

Would you like to talk about GTHP instead of criticizing me with your very first post? Share your DD with us!

The next financial statement will be a 10-K, not a 10-Q. The last couple of 10-Q's and the recent Form 4's explain pretty well "what's happening here." Also, the clinical trial page on clinicaltrials.gov -- that hasn't been updated for year, so it's due.

What’s happening here?
When’s management publishing latest 10-Q?
GetSeriousOK, you want to take side of management then it’s ok. However stop cyber bullying & cyber harassing of management’s critics. You don’t have any rights to do that.
I hope myjo or myjog, whosoever he or she is, he or she is okay.

Thanks for that update - I appreciate it. I'll try to stay on my traxone for the drunkeness an my Bacardi for Myjob.

Welcome back!

Here's what you missed:

To everyone's surprise, SMI got a 400-patient multi-location clinical trial in China COMPLETED and submitted an application to the Chinese FDA. SMI is now supposed to pay Guided $$$ millions but we all know SMI has no money so...... whatever. Still great news IMO because Guided can use include that Chinese clinical trial when they submit to the US FDA which I think will happen in 2025, although.... read next bullet.

Guided finally started their US clinical trials while you were gone, and that might be ending.... well who knows. The last time they updated progress in October, they said "over half [of 400] enrolled," which means over 200, which means.... mid 2025? Here's the clinicaltrials.gov website that I check every now and then to see if the paint has dried. It predicted the trials would end in December 2024 but we all knew that wasn't going to happen. Trials rarely end as scheduled, especially when it's 400 participants.

https://clinicaltrials.gov/study/NCT04915495?tab=results

And they sold some devices and disposables to Indonesia in December, so the financials will have something other than crickets to report at the end of March, even if SMI still hasn't paid them those pie-in-the-sky $$$ millions.

Lots of Form 4's in the past two years. The top three insiders own a lot of stock.

Finally, our resident basher is still at work, although he hasn't been seen since flaming out pretty hard in mid December 2024 . Not sure why he abruptly stopped, but rest assured, he'll be back.


Cheers!

So I was drunk for 2 years. Big deal.

Is this thing still on? I've been wondering why my light bill has been so high for 2 years.

Look up the definition of HYPERBOLE. It's a useful tool when used sparingly, but when you use it in almost every sentence, it's farce.

Your post here is word salad that makes no logical sense. You're demanding that Guided does something that cannot be done.

The problem is, you're making libelous statements. I think Guided Management is going to sue you for libel in 2025, and if they do, it's a slam-dunk case. The only question is whether or not they think you're worth the effort. I guess we'll find out soon. Meanwhile, enjoy the rest of 2024!

I thought you said using words like NEVER is hyperbole? Who’s hyperbole & hypocrite now?
Don’t worry about my health. I’m well capable of taking care of my own health. And if you are so much worried about my health then have a call with full-of-shit GTHP management & ask them to ensure SMI pays them in full by December-end ‘24.
If a deadbeat defaults on a loan, how is that the bank's fault? You are right if the deadbeat defaults on a loan that’s not bank’s fault but then wise & intelligent & clever banks never give an another loan again to the deadbeat defaulter. Whereas here SMI defaulted not only once but many times & yet the non-performing, no-capability, lazy management keeps on giving them chances after chances & partnering with a defaulter & non-trustworthy partner. That’s fraudulent behavior. They say fool me once shame on you but fool me twice shame on me. SMI made a complete fool out of GTHP management not only once but many times. What are GTHP management’s vested interests in keep on partnering with a payment defaulted & non-trustworthy entity? Did SMI pay bribes to GTHP management? Due to their non-performance, no-capability & laziness stockholders suffered 99% losses.
They say where there’s a will there’s a way. If lazy GTHP management would have at least tried to find another trustworthy & paying partner then may be they would have found one. But it appears that the lazy management never tried that search option.
If GTHP management can’t find a way to ensure SMI pays 1.34ML$ by year end ‘24, then they are not worthy of their jobs. To find a way is their job & if they can’t do that then they don’t deserve their jobs. Why they need a common stockholder to inform them how to do their jobs & a way about how to make their partner pay? Don’t they know how to do their jobs? If hey know then they must find a way to ensure SMI pays them in full by December-end ‘24.
For the last time don’t bother to reply to my any posts on any forum ever again anywhere.

Guided could NEVER have found anyone else to do all that work for free. SMI was a godsend, regardless of whether they pay Guided any money or not.

57,000 shares is not a selloff.

When I say that you're full of shit, notice that I'm not calling you an idiot or "intellectually challenged" or dim-witted or stupid. It's just an observation that your hyperbole-laden posts are lies and that anyone who uses two aliases to create a fake conversation and/or buys the stock while bashing is full of shit.

You are getting very angry and I'm worried about your health. Please go pet a dog or give a dollar to a homeless person and try to let that anger go. Celebrate life. You shouldn't care that I see through you. You still managed to buy a fair amount of this stock under a dime in the past year, didn't you? So congratulations!

For an intellectually challenged individual like you no wonder I’ve to repeat myself. So here we go again. I don’t get angry ever & I certainly don’t get angry at idiots, stupids & dim-witted. I pity their intelligence (if they have any). Next time before you call me names like full of shit, take a look in the mirror & may be a realization of a “light bulb” moment.
If you are so bullish on the stock why do t you buy at ask price? You don’t buy because you are full of shit & a paid pumper.
When the 1st time SMI didn’t obey their contractual payment obligations, at that time itself GTHP management should have started to search for another paying, trustworthy partner. However lazy & no-capacity GTHP management didn’t do that. Now SMI fully know that GTHP is stuck with them & SMI is exploiting the undue disadvantage of GTHP’s situation to their fullest to their own selfish advantage.
I suspect that SMI has already informed GTHP about that they can’t pay 1.34ML$ by this year end & somehow that insider information was leaked to the market today & hence the sell off today.
Stockholders lost 99% of value in stock solely because of non-performing, no-capability, lazy management.

I own a lot of GTHP stock. Probably not as much as YOU, considering how you've been steadily buying while bashing, but I own a lot.

GTHP management owns a lot of GTHP stock too.

Please explain why is SMI's inability to pay the fault of GTHP management? If a deadbeat defaults on a loan, how is that the bank's fault?

How do you propose GTHP management "[ensures] SMI pays them 1.34ML$ in full by December 31st 2024?" Travel to China and threaten to break their thumbs?

Do you think Shenghuo would have ever completed a 400-patient clinical trial in China and submitted an application to the NMPA?

Do you think GTHP management could have found anyone ELSE to do all that for free?

How can you expect anyone to not think you're full of shit when you're so full of shit?

LOL I'm sorry, it's wrong for me to pick on you like this. It's making you angry and that's not in the Holiday Spirit. I'm interfering with your bashing and buying, aren't I? I'll stop. Happy Holidays!

If you are so bullish on the stock & company, where are your buys? Put your money where your mouth is.
We shall soon see if GTHP management has what it takes to ensure SMI pays them 1.34ML$ in full by December 31st 2024.

Do you deny using two aliases to create a fake conversation bashing this stock? Aliases myjo and myjog?

And do you deny buying the stock while you were bashing? Even though you admitted that you and your associates were buying while you were bashing?

I can show you those posts if you want to see them again.

Don't you agree that someone who used two aliases to fake a conversation is full of shit?

And don't you agree that someone who is buying a stock while bashing it is full of shit?

You say "Data doesn't lie." Look at the historical data for daily volume for the past YEAR and note the days that had 100,000 volume or more:

* none in November
* three days in October
* none in September or August
* one day each in July, June, May, April....
* two days in March....
* three days in February....
* and none in January.

There were more days that had ZERO volume than days that had 100,000 volume. Typical daily volume is under 10,000 shares -- under $2000 per day. That's the data and it doesn't lie. Your FUD doom-and-gloom about selling and dumping and "massive volume" is proven false by the data you claim to trust.

But don't let me stop you from taking your own advice and shorting this stock. We'll watch your progress on REGSHO.

And have you looked up the definition of "hyperbole" yet? Words like ever, never, always, absolutely.... When someone uses hyperbole as much as you, it loses its effect. It makes you sound childish. You might want to dial it back.

I don’t get angry ever & I certainly don’t get angry at idiots, stupids & dim-witted. I pity their intelligence (if they have any). Next time before you call me names like full of shit, take a look in the mirror & may be a realization of a “light bulb” moment.
Data doesn’t lie.
I’m bearish right from the beginning get-go because of poor-performing & no-capacity management have a great product at hand & they are literally ruining the stock. In last 8-+ years, management made stockholders 99% of losses & still management enriched themselves by awarding dividend & all kind of stock payments at the expense of stockholders’ losses.
We shall see if management has what it takes to make SMI pay them 1.34ML$ at then end of this year. Just 14 more days remaining. Clock is ticking. Tick-tock-tick-tock.
Looking at today’s trading my “guess” is that SMI is not paying them a dime & that insider news was leaked to market.

That's your advice? "short it?"

Short a penny stock trading at 16 cents?

BTW when I said there was no volume the volume was 2000 shares. Did you buy 55,000 shares just to prove me wrong? LOL it'll take more than 55,000 shares to create volume here. The next catalyst will be either a big payment from SMI or the completion of the USA clinical trials. Until then, there's not going to be any volume, unless Auctus or some other big holder decides to dump.

You seem angry. That's a shame. It's the holiday season! Cheer up. Maybe bring back your second alias and create another fake conversation so you have someone other than me to talk to!

Paid pumpers are saying there’s no volume. The fact & truth & data says that there are almost 55K net sells at any salvage price anyone can get. Who’s full of shit now? Data doesn’t lie. Paid pumpers are full of shit. Bid is at 0.155$ & there are neither any buyers nor any buying support. Where are paid pumpers’ buys? They are full of shit, lies & bs. This is going down. Short it.

It’s a sell, sell, sell. Sell at any salvage price you can get. Short this. This is going down the toilet. Paid pumpers are full of shit. They are not buying. If any one have any courage to buy, then show your buys. Otherwise you are full of shit. Show your buys!

Level 2 shows that you're full of shit.

There's no "unlimited supply of GTHP stock" and the MM's aren't doing anything illegal. There's simply no volume here and there won't be until there's a significant catalyst.

The entire time you've been bashing, you've been buying, or trying to buy anyway. Where do your Bids currently sit? And do you think you can drive the PPS down to your price by bashing every day?

No matter how many buys are done at an ask price of 0.175$, it appears that broker-dealers / market-makers have an unlimited supply of GTHP stock to be sold at 0.175$ price. Bid stubbornly sits at 0.17$ & never goes up! What a mess this stock has become!

That’s your opinion .
Keep your BS opinions to yourself.
If you have value add information about GTHP then post here. Otherwise don’t ever bother to reply to any of my posts on any forum anywhere ever.

Stop posting bullshit and FUD about GTHP and nobody will ever respond to you again.

Keep posting bullshit and FUD about GTHP and you'll have to put up with people calling you out.

If any of those 2 things don’t happen then never ever bother to reply to any of my posts ever again on any forum anywhere.
Whether or not SMI will pay GTHP 1.34ML$ by 12/31/2024 is going to be known in next 15 days anyway.